SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IMNR - Immune Response
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: margie who wrote (1379)6/8/1999 10:53:00 AM
From: Don Hurst  Read Replies (2) of 1510
 
Margie, you are very,very good. Thanks for your post.

Below is something posted yesterday on the Yahoo thread about IMNR and its' cancer activities. If true, it should be quite positive for IMNR
IMO. What do you think about this area of IMNR's activities?

I have not seen this news release from IMNR yet which makes me wonder if this post is correct.

"patent
by: forty_something2
9761 of 9781
membrane-bound cytokine-containing antitumor vaccines covered by U.S. patent

A U.S. patent (patent: US 5891432) has been issued to Immune Response covering the use of granulocyte-macrophage colony-stimulating factor (GM-CSF) expressed in membrane-bound form to induce a powerful antitumor immune response. The as a vaccine designed to stimulate the immune system to destroy the cancer. The immune-activating cytokine GM-CSF is bound to the membrane of the tumor cells, which results in a more effective, genetically altered tumor cell vaccine than existing
vaccines, as demonstrated in preclinical models in mice, where complete protection from tumor challenge has been obtained using this membrane-bound technology. These findings are scheduled for publication in the June 15, 1999 issue of the Journal of Immunology (Immune Response News Release). "


Regards,

Don

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News